Nalaganje...

Immuno-targeting of pancreatic cancer stem cells: A new therapeutic strategy against a devastating disease?

Pancreatic cancer is a highly aggressive and deadly disease harboring a distinct population of cancer stem cells (CSC) that is not affected by conventional therapies. A new therapeutic approach using the EpCAM/CD3-bispecific antibody MT110 is capable of activating and redirecting cytotoxic T cells t...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Cioffi, Michele, Heeschen, Christopher
Format: Artigo
Jezik:Inglês
Izdano: Landes Bioscience 2012
Teme:
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3382890/
https://ncbi.nlm.nih.gov/pubmed/22754787
Oznake: Označite
Brez oznak, prvi označite!